enGene Therapeutics Inc. (ENGN) — Total Assets

Annual figures by fiscal year, from SEC filings.

2022: $23.91M2023: $86.96M2024: $311.17M2025: $221.47M$221.47M
2022Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$221.47M-28.8%
2024$311.17M+257.8%
2023$86.96M+263.7%
2022$23.91M